Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases

With the emergence of precision medicine, treatment strategies for neurodegenerative diseases are becoming increasingly tailored to individual patients based on their genetic, molecular, and clinical profiles. This session will highlight biomarker-driven clinical trials, pharmacogenomics, and AI-powered patient stratification in developing personalized interventions. Case studies of successful precision medicine approaches in Alzheimer’s, Parkinson’s, and ALS will be presented. This session is valuable for clinicians, researchers, and biotech professionals involved in personalized neurology care.

    Related Conference of Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases

    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland

    Personalized Medicine and Biomarker-Driven Approaches in Neurodegenerative Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in